Biblio Discovery — Demo Discovery Service

14 hasil untuk "Nazir Ismail"

Menampilkan 1–14 · 5,06 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Feasibility of using postal and web-based surveys to estimate the prevalence of tuberculosis among health care workers in South Africa

    Pinky N. Manana; Lazarus Kuonza; Alfred Musekiwa dkk.

    PLOS ONE, Vol. 13 No. 5 · 2018 · Inggris · PLOS Scopus

    Introduction: Health Care Workers (HCWs) are among the highest risk groups for contracting tuberculosis (TB), which is ranked the third most common occupational health disease in South Africa. Little is known about the true extent of the burden of TB among South African HCWs and current…

  2. Artikel Jurnal Teks lengkap

    Concurrent use of low complexity automated NAATs for TB diagnosis and detection of resistance: A cost-effectiveness analysis

    Suvesh Kumar Shrestha; Funeka Bango; Pushpita Samina dkk.

    PLOS Global Public Health, Vol. 5 No. 8 · 2025 · Inggris · PLOS Scopus

    Current TB diagnostics relying on respiratory samples are less effective in children (under 10 years), children living with HIV (CLHIV) and adult people living with HIV (PLHIV). Concurrent testing using low-complexity automated nucleic acid amplification tests (LC-aNAATs) on multiple sample types…

  3. Artikel Jurnal Teks lengkap

    A combination of baseline plasma immune markers can predict therapeutic response in multidrug resistant tuberculosis

    Selena Ferrian; Claudia Manca; Sugnet Lubbe dkk.

    PLOS ONE, Vol. 12 No. 5 · 2017 · Inggris · PLOS Scopus

    Objective: To identify plasma markers predictive of therapeutic response in patients with multidrug resistant tuberculosis (MDR-TB). Methods: Fifty HIV-negative patients with active pulmonary MDR-TB were analysed for six soluble analytes in plasma at the time of initiating treatment (baseline) and…

  4. Artikel Jurnal Teks lengkap

    WHO target product profile for TB detection at peripheral settings: 2024 update

    Mikashmi Kohli; Alexei Korobitsyn; Nazir Ismail dkk.

    PLOS Global Public Health, Vol. 5 No. 6 · 2025 · Inggris · PLOS Scopus

    In 2014, the World Health Organization (WHO) published target product profiles (TPPs) which detailed minimal and optimal criteria to address high-priority TB diagnostic needs. Since then, the TB community’s needs have evolved; there has been a surge in new and innovative platforms suggesting use of…

  5. Artikel Jurnal Teks lengkap

    Cost-Effectiveness of Automated Digital Microscopy for Diagnosis of Active Tuberculosis

    Swati Jha; Nazir Ismail; David Clark dkk.

    PLOS ONE, Vol. 11 No. 6 · 2016 · Inggris · PLOS Scopus

    Background: Automated digital microscopy has the potential to improve the diagnosis of tuberculosis (TB), particularly in settings where molecular testing is too expensive to perform routinely. The cost-effectiveness of TB diagnostic algorithms using automated digital microscopy remains uncertain…

  6. Artikel Jurnal Teks lengkap

    Comparative accuracy of the REBA MTB MDR and Hain MTBDR plus line probe assays for the detection of multidrug-resistant tuberculosis: A multicenter, non-inferiority study

    Joshua Havumaki; Doris Hillemann; Nazir Ismail dkk.

    PLOS ONE, Vol. 12 No. 3 · 2017 · Inggris · PLOS Scopus

    Introduction: Despite recent diagnostic advances, the majority of multidrug-resistant tuberculosis (MDR-TB) cases remain undiagnosed. Line probes assays (LiPAs) hold great promise to curb the spread of MDR-TB as they can rapidly detect MDR-TB even when laboratory infrastructure is limited, yet few…

  7. Artikel Jurnal Teks lengkap

    Economic evaluation of novel Mycobacterium tuberculosis specific antigen-based skin tests for detection of TB infection: A modelling study

    Lara Goscé; Kasim Allel; Yohhei Hamada dkk.

    PLOS Global Public Health, Vol. 3 No. 12 · 2023 · Inggris · PLOS Scopus

    Evidence on the economic impact of novel skin tests for tuberculosis infection (TBST) is scarce and limited by study quality. We used estimates on the cost-effectiveness of the use of TBST compared to current tuberculosis infection (TBI) tests to assess whether TBST are affordable and feasible to…

  8. Artikel Jurnal Teks lengkap

    Using mHealth to improve tuberculosis case identification and treatment initiation in South Africa: Results from a pilot study

    Noriah Maraba; Christopher J. Hoffmann; Violet N. Chihota dkk.

    PLOS ONE, Vol. 13 No. 7 · 2018 · Inggris · PLOS Scopus

    Background: Tuberculosis (TB) incidence in South Africa is among the highest globally. Initial loss to follow-up (ILFU), defined as not starting on TB treatment within 28 days of testing positive, is undermining control efforts. We assessed the feasibility, acceptability, and potential of a mHealth…

  9. Artikel Jurnal Teks lengkap

    Incidence and Geographic Distribution of Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal Province, South Africa

    Jennifer R. Lim; Neel R. Gandhi; Thuli Mthiyane dkk.

    PLOS ONE, Vol. 10 No. 7 · 2015 · Inggris · PLOS Scopus

    South Africa is experiencing a widespread drug-resistant tuberculosis epidemic, although data are limited regarding the current situation. This study finds that the extensively drug-resistant tuberculosis (XDR-TB) incidence in KwaZulu-Natal increased to 3.5 cases/100,000 (776 cases) in 2011-2012…

  10. Artikel Jurnal Teks lengkap

    A Subset of Circulating Blood Mycobacteria-Specific CD4 T Cells Can Predict the Time to Mycobacterium tuberculosis Sputum Culture Conversion

    Catherine Riou; Clive M. Gray; Masixole Lugongolo dkk.

    PLoS ONE, Vol. 9 No. 7 · 2014 · Inggris · PLOS Scopus

    We investigated 18 HIV-negative patients with MDR-TB for M. tuberculosis (Mtb)- and PPD-specific CD4 T cell responses and followed them over 6 months of drug therapy. Twelve of these patients were sputum culture (SC) positive and six patients were SC negative upon enrollment. Our aim was to…

  11. Artikel Jurnal Teks lengkap

    Updating the WHO target product profile for next-generation Mycobacterium tuberculosis drug susceptibility testing at peripheral centres

    Emily Lai-Ho MacLean; Paolo Miotto; Lice González Angulo dkk.

    PLOS Global Public Health, Vol. 3 No. 3 · 2023 · Inggris · PLOS Scopus

    There were approximately 10 million tuberculosis (TB) cases in 2020, of which 500,000 were drug-resistant. Only one third of drug-resistant TB cases were diagnosed and enrolled on appropriate treatment, an issue partly driven by a lack of rapid, accurate drug-susceptibility testing (DST) tools…

  12. Artikel Jurnal Teks lengkap

    Systematic review of the economic impact of novel Mycobacterium tuberculosis specific antigen-based skin tests for detection of TB infection compared with tuberculin skin test and interferon-gamma release assays

    Lara Goscé; Kasim Allel; Yohhei Hamada dkk.

    PLOS Global Public Health, Vol. 4 No. 10 · 2024 · Inggris · PLOS Scopus

    The Purified Protein Derivative tuberculin skin tests (TST) and blood-based Mycobacterium tuberculosis (M.tb) specific interferon-gamma release assays (IGRA) are the currently used tests for identifying individuals with TB infection for preventive treatment. However, challenges around access and…

  13. Artikel Jurnal Teks lengkap

    Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: A multicountry analysis of cross-sectional data

    Anna S. Dean; Matteo Zignol; Andrea Maurizio Cabibbe dkk.

    PLOS Medicine, Vol. 17 No. 1 · 2020 · Inggris · PLOS Scopus

    Background: The surveillance of drug resistance among tuberculosis (TB) patients is central to combatting the global TB epidemic and preventing the spread of antimicrobial resistance. Isoniazid and rifampicin are two of the most powerful first-line anti-TB medicines, and resistance to either of…